Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

ICL Group (ICL.TA)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date	Stock Price (NIS)	Price Target (NIS)	Rating
2022-02-28	36.40	28.00	Neutral
2022-05-27	37.80	38.00	Neutral
2022-07-14	31.00	31.00	Neutral
2022-10-06	29.41	29.00	Neutral
2023-03-20	23.95	26.00	Neutral
2023-04-13	23.24	24.00	Neutral
2023-05-24	22.60	23.00	Neutral
2023-06-29	20.10	21.00	Neutral
2023-11-10	18.93	20.00	Neutral
2023-12-13	17.83	19.00	Neutral
2024-01-22	16.98	18.00	Neutral
2024-03-04	19.08	19.00	Neutral
2024-10-14	14.93	17.00	Neutral
2024-11-22	16.89	18.00	Neutral
2025-04-07	21.04	22.00	Neutral

Disclosures

UBS Securities LLC makes a market in the securities and/or ADRs of this company.

Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.